Eyal Zur

Summary

Publications

  1. ncbi Eosinophilic esophagitis: treatment with oral viscous budesonide
    Eyal Zur
    Central Laboratory of Super Pharm, Yarkon Center, Petach Tikvah, Israel
    Int J Pharm Compd 16:288-93. 2012
  2. ncbi Nausea and vomiting in pregnancy: a review of the pathology and compounding opportunities
    Eyal Zur
    Super Pharm Professional, Petach Tikva, Israel
    Int J Pharm Compd 17:113-23. 2013
  3. ncbi Compounding slow-release capsules: a comprehensive review and an Excel spreadsheet for faster calculations of excipients
    Eyal Zur
    Super Pharm Professional, Petach Tikva, Israel
    Int J Pharm Compd 17:10-22. 2013
  4. ncbi Topical use of sodium cromoglicate (cromolyn sodium) to treat atopic dermatitis and other skin allergies
    Eyal Zur
    Super Pharm, Petach Tikvah, Israel
    Int J Pharm Compd 16:386-93. 2012
  5. ncbi Burning mouth syndrome: a discussion of a complex pathology
    Eyal Zur
    Super Pharm, Petach Tikvah, Israel
    Int J Pharm Compd 16:196-205. 2012
  6. ncbi Oral mucositis: etiology, and clinical and pharmaceutical management
    Eyal Zur
    Super Pharm, Petach Tikvah, Israel
    Int J Pharm Compd 16:22-33. 2012
  7. ncbi Gastrointestinal mucositis: focus on the treatment of the effects of chemotherapy and radiotherapy on the rectum
    Eyal Zur
    Yarkon Center, Petach Tikvah, Israel
    Int J Pharm Compd 16:117-24. 2012

Detail Information

Publications7

  1. ncbi Eosinophilic esophagitis: treatment with oral viscous budesonide
    Eyal Zur
    Central Laboratory of Super Pharm, Yarkon Center, Petach Tikvah, Israel
    Int J Pharm Compd 16:288-93. 2012
    ..Since there are no commercial medicines of oral viscous budesonide, it is solely a compounded medication. This article briefly discusses the properties of the disease and covers a few compounding possibilities to oral viscous budesonide...
  2. ncbi Nausea and vomiting in pregnancy: a review of the pathology and compounding opportunities
    Eyal Zur
    Super Pharm Professional, Petach Tikva, Israel
    Int J Pharm Compd 17:113-23. 2013
    ..This review summarizes the nausea and vomiting in pregnancy problems and discusses the compounding opportunities that exist in this common and wide-spread pathology in order to improve a woman's quality of life...
  3. ncbi Compounding slow-release capsules: a comprehensive review and an Excel spreadsheet for faster calculations of excipients
    Eyal Zur
    Super Pharm Professional, Petach Tikva, Israel
    Int J Pharm Compd 17:10-22. 2013
    ..The regulatory aspect of compounding slow-release capsules is also discussed...
  4. ncbi Topical use of sodium cromoglicate (cromolyn sodium) to treat atopic dermatitis and other skin allergies
    Eyal Zur
    Super Pharm, Petach Tikvah, Israel
    Int J Pharm Compd 16:386-93. 2012
    ....
  5. ncbi Burning mouth syndrome: a discussion of a complex pathology
    Eyal Zur
    Super Pharm, Petach Tikvah, Israel
    Int J Pharm Compd 16:196-205. 2012
    ..Compounding topical preparations of clonazepam offers opportunities for compounding pharmacists to be more involved in improving the quality of life of burning mouth syndrome patients...
  6. ncbi Oral mucositis: etiology, and clinical and pharmaceutical management
    Eyal Zur
    Super Pharm, Petach Tikvah, Israel
    Int J Pharm Compd 16:22-33. 2012
    ..Expansion of the knowledge of the pathogenesis of mucositis as well as a better insight into individual risk factors will provide opportunities to improve management strategies...
  7. ncbi Gastrointestinal mucositis: focus on the treatment of the effects of chemotherapy and radiotherapy on the rectum
    Eyal Zur
    Yarkon Center, Petach Tikvah, Israel
    Int J Pharm Compd 16:117-24. 2012
    ..As in oral mucositis, although substantial scientific progress has been made in learning more about this pathology, current treatments to manage gastrointestinal mucositis is inadequate...